Efficacy and Safety of Syk and BTK Inhibitors in Immune Thrombocytopenia: A Comprehensive Review of Emerging Evidence.

Mediators Inflamm · 2025 · PMC12084790 · PMID 40385351

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The incidence of bleeding, as measured by the WHO bleeding score, showed a decreasing trend from baseline to week 24 in the sovleplenib group.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.